Takada K, Samura M, Igarashi Y, Suzuki A, Ishigo T, Fujii S
J Pharm Health Care Sci. 2025; 11(1):18.
PMID: 40075546
PMC: 11900651.
DOI: 10.1186/s40780-025-00423-8.
Liu W, Li X, Chen L, Luo X
BMC Endocr Disord. 2025; 25(1):67.
PMID: 40065306
PMC: 11895387.
DOI: 10.1186/s12902-025-01891-7.
Kicken M, Deenen M, van der Wekken A, van den Borne B, van den Heuvel M, Ter Heine R
Clin Pharmacokinet. 2025; .
PMID: 40045151
DOI: 10.1007/s40262-025-01492-6.
Shima Y, Yoshida H, Suminaga K, Yoshida H, Hashimoto K, Ogimoto T
BMC Cancer. 2025; 25(1):388.
PMID: 40038680
PMC: 11877893.
DOI: 10.1186/s12885-025-13785-x.
Wang Y, Zhao Q, Zheng X, Zhang K
Ren Fail. 2025; 47(1):2473668.
PMID: 40038268
PMC: 11884092.
DOI: 10.1080/0886022X.2025.2473668.
Sampling from covariate distribution may not always be necessary in PK/PD simulations: illustrative examples with antibiotics.
Liu F, Cheng Z, Li S, Xie F
J Pharmacokinet Pharmacodyn. 2025; 52(2):19.
PMID: 40038131
DOI: 10.1007/s10928-025-09967-6.
Population pharmacokinetics of colistin sulfate in patients on continuous veno-venous hemodiafiltration.
Huang T, Luo Y, Wu Y, Niu L, Xiao Y, Wu T
Sci Prog. 2025; 108(1):368504251325334.
PMID: 40033936
PMC: 11877486.
DOI: 10.1177/00368504251325334.
Population Pharmacokinetics-Based Evaluation of Ceftazidime-Avibactam Dosing Regimens in Critically and Non-Critically Ill Patients With Carbapenem-Resistant .
Chen Y, Chen B, Huang Y, Li X, Wu J, Lin R
Infect Drug Resist. 2025; 18:941-955.
PMID: 39990787
PMC: 11846486.
DOI: 10.2147/IDR.S495279.
Impact of insurance coverage for non-vitamin K antagonist oral anticoagulants on quality of care and care disparities in patients hospitalised with atrial fibrillation in tertiary hospitals in China: interrupted time series analysis.
Yang N, Sun Z, Liu J, Hao Y, Long D, Zhao D
BMJ Open. 2025; 15(2):e088539.
PMID: 39986999
PMC: 11848658.
DOI: 10.1136/bmjopen-2024-088539.
Vancomycin dosing design method considering risk factors for nephrotoxicity.
Matsuki Y, Kozima Y, Yanagi M, Sako K, Watanabe T, Yasuno N
J Pharm Health Care Sci. 2025; 11(1):14.
PMID: 39985007
PMC: 11846157.
DOI: 10.1186/s40780-025-00416-7.
Navigating pharmacokinetic and pharmacodynamics challenges of β-lactam antibiotics in patients with low body weight: efficacy, toxicity, and dosage optimization.
Tseng Y, Tai C, Chen G, Chen Y, Ku S, Pai T
Ther Adv Drug Saf. 2025; 16:20420986251320414.
PMID: 39974281
PMC: 11837059.
DOI: 10.1177/20420986251320414.
Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV.
Chawana T, Walsh S, Stranix-Chibanda L, Chirenje Z, Yu C, Zhang L
BMC Immunol. 2025; 26(1):8.
PMID: 39966732
PMC: 11837431.
DOI: 10.1186/s12865-025-00687-7.
Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?.
Kefale B, Peterson G, Mirkazemi C, Dwyer N, Salahudeen M, Radford J
Eur J Clin Invest. 2025; 55(4):e70011.
PMID: 39950225
PMC: 11891822.
DOI: 10.1111/eci.70011.
Establishing discordance rate of estimated glomerular filtration rate between serum creatinine-based calculations and cystatin-C-based calculations in critically ill patients.
Williams V, Gerlach A
Pharmacotherapy. 2025; 45(3):161-168.
PMID: 39945448
PMC: 11905338.
DOI: 10.1002/phar.70000.
Colistin Use for the Treatment of Multi-Drug-Resistant Gram-Negative Severe Infections in ICU Patients: A Single-Center Study.
Rojek S, Wojtowicz I, Taccone F, Duszynska W
J Clin Med. 2025; 14(3).
PMID: 39941468
PMC: 11818872.
DOI: 10.3390/jcm14030797.
Renal function and adverse clinical events in anticoagulated patients with atrial fibrillation: insights from the GLORIA-AF Registry Phase III.
Liu Y, Lam S, Romiti G, Huang B, Chen Y, Chao T
J Thromb Thrombolysis. 2025; 58(2):165-177.
PMID: 39924624
PMC: 11885355.
DOI: 10.1007/s11239-025-03067-5.
Biomarkers of residual risk and all-cause mortality after acute coronary syndrome.
Toso A, Leoncini M, Maioli M, Villani S, Bellandi F
Am J Prev Cardiol. 2025; 21:100934.
PMID: 39896052
PMC: 11787588.
DOI: 10.1016/j.ajpc.2025.100934.
Effect of prophylactic doses of enoxaparin on antifactor Xa activity confirmed by rotational thromboelastometry in critically ill patients: a preliminary prospective cohort study.
Czempik P, Beberok A
Front Pharmacol. 2025; 15:1498188.
PMID: 39881863
PMC: 11774899.
DOI: 10.3389/fphar.2024.1498188.
Performance of Creatinine and Cystatin-Based Equations on Estimating Measured GFR in People with Hematological and Solid Cancers.
Titan S, Lieske J, Meeusen J, Thorson S, Lin Y, Nowakowski G
Clin J Am Soc Nephrol. 2025; 20(3):358-366.
PMID: 39874103
PMC: 11905996.
DOI: 10.2215/CJN.0000000616.
Kidney function estimation equations: a narrative review.
Khader N, Kamath V, Kamath S, Rao I, Prabhu A
Ir J Med Sci. 2025; .
PMID: 39873963
DOI: 10.1007/s11845-025-03874-y.